• Tech
• Gadgets
• Mobile
• Enterprise
• CrunchBase
• More
  • Beta Invites
  • Elevator Pitches
  • Gillmor Gang
  • Podcasts
  • TechCrunch50
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Rib-X Pharmaceuticals

edit

Rib-X Pharmaceuticals, Inc. is a product-driven small molecule drug discovery and development company focused on the structure based design of new classes of antibiotics.

Milestones

edit

• 
  Rib-X Pharmaceuticals received $25M in Unattributed funding. (1/25/09)
  Posted 4/17/09 at 8:17am

Videos

Screenshots

edit

Above: Home Page
Uploaded: 5/9/09

Sources

1. Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing (rib-x.com) [edit]